Tetralogy of fallot screening: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Tetralogy of fallot}} {{CMG}}; {{AE}} {{Fs}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR According..." |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
==Screening== | ==Screening== | ||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with: | According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with: | ||
*[Condition 1] | *[Condition 1] | ||
Revision as of 19:26, 13 February 2020
|
Tetralogy of fallot Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
|
|
Tetralogy of fallot screening On the Web |
|
American Roentgen Ray Society Images of Tetralogy of fallot screening |
|
Risk calculators and risk factors for Tetralogy of fallot screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
Screening
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]